Colgate-Palmolive may be preparing to sell some of the most familiar brands in American bathrooms.
The consumer-products company is considering divesting personal-care brands including Softsoap, Irish Spring and Speed Stick, according to Reuters. Goldman Sachs is advising on the potential process, which could bring in more than $1 billion.
That does not mean a deal is guaranteed. Colgate has not announced a sale, and the brands could remain inside the company if bids do not meet management's expectations. But even the consideration of a sale says something important about how a major consumer-products company is thinking about growth.
Colgate-Palmolive is looking harder at what it owns, where it has the strongest competitive position and which businesses deserve more capital. The company is not selling obscure assets. It is evaluating household names that millions of consumers recognize.
The apparent strategy is portfolio concentration. Colgate's personal-care division represented about 17% of 2025 net sales, or approximately $3.5 billion. Oral care remains the company's largest business and its clearest identity. Selling selected soaps and deodorants could allow Colgate to focus more heavily on toothpaste, toothbrushes and related products while giving management additional capital to deploy.
The timing is revealing. Colgate reported a 4.9% increase in net sales in its latest earnings, but organic sales in North America fell 3%. Chief Executive Noel Wallace has acknowledged competitive pressure and emphasized the need for a longer-term turnaround in the region.
That combination creates a familiar consumer-goods dilemma. Reported sales can rise because of pricing, foreign exchange or acquisitions while the underlying volume of products sold weakens. If consumers buy less or shift toward cheaper alternatives, management eventually has to decide whether to spend more to defend market share or simplify the portfolio.
Colgate appears to be considering the second option.
There is a straightforward financial case for selling the brands. A divestiture could turn slower or less strategic assets into cash immediately. Colgate could use the proceeds for debt reduction, share repurchases, marketing, product development or acquisitions in businesses with better growth prospects. Those are potential uses, not announced plans, but the flexibility itself has value.
The company could also reduce organizational complexity. Running a large consumer-products portfolio requires separate marketing budgets, retail negotiations, product launches and innovation plans across several categories. A narrower company may be easier to manage and may allow executives to put more resources behind the categories where Colgate has the strongest brand recognition and distribution.
The risk is that familiar brands can be more valuable than their recent growth suggests. Softsoap, Irish Spring and Speed Stick have established shelf space, repeat customers and long histories. A buyer could believe it can improve those brands with better marketing, lower costs or a different distribution strategy. If that happens, Colgate may be selling future upside to raise cash today.
There is also a question about scale. Consumer-products companies often benefit from spreading advertising, research and distribution costs across a broad group of brands. Removing a meaningful part of the personal-care portfolio could reduce that advantage, particularly if the remaining business grows more slowly than expected.
Investors should be careful not to treat the potential sale as proof that Colgate's entire business is weakening. The company remains a major global operator with a powerful oral-care franchise. The latest sales increase also shows that the business is still capable of producing growth on a reported basis.
But investors should not treat the move as automatically positive either. The value will depend on the price Colgate receives and what management does with the proceeds. A high-quality divestiture can improve focus and returns. A rushed sale at a weak valuation can simply make the company smaller.
The next signals to watch are clear. First, investors need to see whether Colgate confirms a formal process and identifies exactly which brands are included. Second, they should watch the proceeds and the buyer interest, because a $1 billion headline estimate does not guarantee a $1 billion transaction. Third, they should track North American organic volume, pricing and market share after the portfolio decision.
The most important question is whether Colgate can grow its core businesses after becoming simpler. If oral care and other remaining categories gain investment and momentum, the divestitures could look like disciplined capital allocation. If sales continue to soften, the market may view the move as an attempt to raise cash while avoiding the deeper problem.
Colgate is not abandoning the brands consumers know. It may be deciding that owning every familiar brand is no longer the best way to create shareholder value. That makes the potential sale more than a consumer-products transaction. It is a test of whether a century-old company can become more focused without losing the scale that made those brands valuable in the first place.
